Skip to main content

TB236

Product Details
WHO Product ID
TB236
Status
Prequalified
INN, dosage form and strength
Cycloserine Capsules, hard 250mg
Date of prequalification
Basis of listing
Prequalification - Full
Therapeutic area
Tuberculosis
Type
Finished Pharmaceutical Product
Dosage form
Capsules, hard
Applicant organization
Dong-A ST Co Ltd
64, Cheonho-daero, Dongdaemun-gu
Seoul,
130 708
Korea, Rep.
Packaging details and storage conditions
Packaging Type
Blister, Alu/Alu
Configuration
10x10
Shelf life (months)
48
Storage conditions
Do not store above 30°C, protect from moisture
API Manufacturing Site(s)
By Organization
By Active Ingredient
ST Pharm Co Ltd
Sihwa Site, 231, Hyeomnyeok-ro, Siheung-si
15086
Republic of Korea
Cycloserine
ST Pharm Co. Ltd
Banwol Site 2, 171, Haean-ro, Danwon-gu
Ansan-si,
15610
Korea, Rep.
Cycloserine
FPP Manufacturing Site(s)
Dong-A ST Co Ltd
2F SectionB, 3F, 4F SectionB, 200-23. Baekseokgongdan 1-ro,, Seobuk-gu
Cheonan-si,
31093
Korea, Rep.
WHO Public Assessment Reports


Part 1 - Abstract
Part 2 - All accepted presentations (including photo)
Part 3 - WHO-PQ recommended patient information leaflet*
Part 4 - WHO-PQ recommended summary of product characteristics*
Part 5 - Label
Part 6 - Discussion (status at the time of prequalification)
Part 7 - Steps before Prequalification
Part 8 - Steps following Prequalification (from 01 March 2014, only changes to the published information are included)

* This summary of product characteristics/patient information leaflet focus on uses of the medicine covered by WHO Prequalification Team - Medicines. The recommendations for use are based on WHO guidelines and on information from stringent regulatory authorities (term to be revised). The medicine may be authorised for additional or different uses by national medicines regulatory authorities. 

Part 1 , Part 2 , Part 3 , Part 4 , Part 5 , Part 6 , Part 7 , Part 8

.